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SUMMARY
To quantify the host genetic component of meningococcal disease (MD) susceptibility, the sibling
risk ratio (ls) was calculated as the ratio of observed MD cases among 845 siblings of 443 UK
Caucasian cases to that expected, calculated from age-calendar year speciﬁc rates for England
and Wales. Twenty-seven siblings contracted MD compared with an expected 0.89, generating a
ls value of 30.3. Overestimation of ls due to Neisseria meningitidis exposure was minimized by
excluding siblings with MD onset within set time points of the index case. Irrespective of whether
siblings contracted MD more than 1, 3, 6, 9 or 12 months after the index case, the ls varied
slightly (ls range: 8.2–11.9), suggesting that host genetic factors may contribute approximately
one third of the total ls. Social class distribution did not diﬀer between MD cases and the general
population of England and Wales. This study is the ﬁrst to calculate ls for MD and establishes
that susceptibility to MD has a signiﬁcant host genetic component.
INTRODUCTION
The importance of the host genetic contribution to
infectious disease susceptibility is clearly illustrated by
a greater than ﬁvefold increased risk of dying from an
infective disease in adoptees if a biological parent had
died prematurely of infection. This compares to no sig-
niﬁcant increase in risk associated with the infectious
death of an adoptive parent [1]. A signiﬁcant genetic
component to infectious diseases is also indicated by
twin studies of tuberculosis [2], leprosy [3], malaria
[4] and Helicobacter pylori infection [5] as well as
the many positive associations between diseases and
speciﬁc candidate host gene polymorphisms [6, 7].
Neisseria meningitidis is a commensal and pathogen
in the human nasopharynx and is carried asympto-
matically by approximately 10–15% of the human
population in open communities [8, 9]. Invasive dis-
ease occurs occasionally. Though a number of studies
indicate that host genetics are important in the sus-
ceptibility to meningococcal disease (MD) [10–13],
the relative contribution of host genetics to this sus-
ceptibility has not been quantiﬁed.
The sibling risk ratio of disease, ls, is a standard
parameter used in genetic analysis to indicate the
increased risk of disease in siblings of aﬀected cases
compared with the risk of disease in the general popu-
lation. An increased risk of disease in siblings indi-
cates a host genetic component to susceptibility.
Unbiased estimates of ls are generally diﬃcult to* Author for correspondence.
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calculate for infectious diseases for two reasons: 1)
estimates of ls for infectious diseases tend to over-
estimate the importance of the host genetics because
of the increased risk of exposure to infection in family
members compared with the general population, and
2) the risk of disease in the general population is
generally not known accurately and may vary with
age and calendar year.
In order to take into account the eﬀect of exposure
to N. meningitidis in siblings of aﬀected cases, the
duration between onset of MD in each aﬀected case/
aﬀected sibling(s) pair was also taken into account.
The time between N. meningitidis acquisition and
invasive MD is unknown. Invasive MD is thought
to occur within a few days of pharyngeal acquisition
[14–17] as shown by individuals who contracted MD
having acquired the organism within a week of MD
onset. However, in two prospective studies where
swabs were taken periodically, it was suggested that
N. meningitidis may be carried for longer with acqui-
sition occurring approximately 2 weeks [18] and 7
weeks [19] prior to onset of invasiveMD. To minimize
the eﬀect of increased exposure to N. meningitidis
and thus not overestimate the genetic eﬀect, ls was
calculated using a number of time cut-oﬀs between
the onset of MD in the aﬀected case and the aﬀected
sibling(s) pair. The time cut-oﬀs used were more than
1 week, 1, 3, 6, 9 and 12 months.
Age and calendar year-speciﬁc rates of MD were
used to estimate the number of cases of MD to be ex-
pected by chance among the siblings of aﬀected cases.
METHODS
Information ascertainment
Family information
Between the years 1995 and 2001, a questionnaire was
sent to MD cases located throughout the UK from
two sources : either members of the Meningitis Re-
search Foundation (MRF) or children admitted to the
Paediatric Intensive Care Unit (PICU) at St Mary’s
Hospital, Paddington, London. In cases admitted to
PICU, MD diagnosis was conﬁrmed by one or more
of the following: isolation of meningococci from
blood or CSF, detection of rising meningococcal anti-
bodies or PCR detection of meningococcal genome in
blood or CSF. In patients with no microbiological
conﬁrmation (approximately 13%), MD was diag-
nosed clinically when the patient presented with a
petechial or purpuric rash and fever and features of
systemic sepsis or meningitis where no other pathogen
was isolated despite extensive bacteriological and
virological investigation. Cases recruited via the MRF
had their MD diagnosis conﬁrmed by the local
hospital consultant.
In the questionnaire we sought information on the
number of siblings in each family, their dates of birth,
other aﬀected family members, and dates of all MD
onsets.
Notiﬁcations of meningococcal disease
The Public Health Laboratory Service (PHLS) sup-
plied data on the number of notiﬁcations of meningo-
coccal meningitis and meningococcal septicaemia for
England and Wales for the periods 1974–2000 and
1989–2000 respectively. From 1982–2000, data were
available for yearly age groups (0–97 ando98). From
1974–81, data were available for yearly ages 0–4
and then in the following groupings : ages 5–9, 10–14,
15–24 ando25.
Population data
The Oﬃce for National Statistics (ONS) supplied
population data for England andWales for 1974–2000
by age (0–89 ando90).
Calculation of ls
Calculation of incidence data
For each year (1974–2000) the age speciﬁc risk of
disease was calculated using the data supplied by the
PHLS and the ONS. These data were used to calcu-
late the cumulative risk of MD for each sibling of
each MD case at the time of data ascertainment and
their year of birth. For example, if a questionnaire
was completed in 1999, the risk of disease for an
individual born in 1995 was calculated as the sum of
the risks of MD at age 0 in 1995, age 1 in 1996, age 2
in 1997, age 3 in 1998 and age 4 in 1999. The total risk
of MD in all siblings of aﬀected cases was the sum of
these individual risks. The risk for 1974 was used to
estimate risk for all previous years as notiﬁcations of
MD were either not available or were not considered
accurate prior to this date by the PHLS. The inci-
dence rate for 1974 was no diﬀerent to that for the
following individual 10 years. The risk for 2000 was
used to estimate risk for 2001, as data for 2001 were
incomplete at time of analysis. With the introduction
of the meningococcal C vaccine, the numbers of cases
414 E. Haralambous and others
in 2001 were less than for 2000. This, however, only
generated a slightly higher incidence value for 2001
and, subsequently, slightly underestimated ls.
Calculation of ls
The sibling risk ratio (ls) was calculated as:
ls=
No: of affected siblings of affected cases
expected number of affected siblings
(predicted by incidence data)
To minimize the eﬀect of overestimating ls due to
increased exposure to N. meningitidis, ls was re-
calculated using more than 1 week, 1, 3, 6, 9 and 12
months as cut-oﬀs between the onset of MD in aﬀec-
ted cases and their aﬀected sibling(s). Given that all
but two index cases had MD onset after 1990, at
a time when chemoprophylactic treatment of family
members and close contacts was widely practiced,
stratiﬁcation according to chemoprophylactic treat-
ment administration was not carried out. In addition,
for the two index cases with MD onset before 1991
(one in 1967 and the other in 1977), their aﬀected
siblings contracted MD 20 and 9.1 years respectively
prior to the index case MD onset.
Role of socio-economic factors
To take into account the eﬀect of socio-economic
status, patients were classiﬁed according to the stan-
dard social class grading 1–5 provided by the Census
Dissemination Unit, where geographical areas are
broken down by socio-demographic characteristics,
accessed by postcodes. In this grading, 1 and 5 indicate
the most and least aﬄuent areas respectively (http://
census.ac.uk/cdu/Datasets/1991_Census_datasets/).
RESULTS
Over one thousand UK index cases were identiﬁed
(621 MRF, 436 PICU, total 1057), of whom 648
(396 MRF and 252 PICU) completed a questionnaire
(61.2% response rate). Excluded from the analysis
were 15 pairs of monozygotic (MZ) twins and 34 non-
Caucasian cases. OfUKCaucasianMDcases, 443 had
at least one sibling and were included in the analysis.
There were 845 siblings of the 443 index cases. Of
these, 27 were reported to have contractedMD. There
were no signiﬁcant diﬀerences in the proportions of
aﬀected sibs between the PICU and MRF groups (13
PICU, 14 MRF), nor in the mean (PICU 25.85
months, MRF 17.85 months) or median (PICU 0.5
months, MRF 1.5 months) intervals between dates of
onset of infection in cases and their sibling(s). The two
groups were therefore combined in all analyses.
Of the 27 aﬀected sibling pairs, 11 (40.7%) con-
tracted MD within 1 week of each other, 6 (22.2%)
between 2 weeks and 1 month, 1 (3.7%) at 2 months,
1 (3.7%) at 8 months, 1 (3.7%) at 11 months and 7
(25.9%) after an interval of 12 months or more.
Where over 12 months had elapsed between MD on-
sets, the range extended from 1.3–20 years. In all but
one index case, all index cases had only one aﬀected
sibling. One index case had two aﬀected siblings with
both siblings contracting MD within 1 week of the
index case.
The expected number of cases of MD in the 845
siblings estimated from age and calendar year speciﬁc
population rates was 0.892. Compared with 27 ob-
served cases of aﬀected siblings, this gives a sibling
risk ratio of 30.3 (95% CI 20–44).
In order to separate the relative eﬀects of exposure
toN. meningitidis from host factors (e.g. host genetic),
values of ls were calculated using diﬀerent exclusion
Table 1. Sibling risk ratio by interval between onset of index case and
sibling case
Interval between MD
onsets in index case and
aﬀected sibling(s) pairs
Number of
aﬀected siblings
to index
cases
Expected
number
of aﬀected
siblings ls (95% CI)
All data 27 0.892 30.3 (20.0–44.0)
>1 week 16 0.878 18.2 (10.4–30.0)
>1 month 10 0.842 11.9 (5.7–21.8)
>3 months 9 0.859 10.5 (4.8–19.9)
>6 months 9 0.859 10.5 (4.8–19.9)
>9 months 8 0.854 9.4 (4.0–18.5)
>12 months 7 0.822 8.2 (3.4–17.9)
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criteria (Table 1). The highest ls was for cases occur-
ring within 1 week of each other. There was little
diﬀerence in ls when there was more than 1 month
between cases. Excluding pairs where the onset of the
second case was more than 1 year after the date of
onset of the index case, the sibling risk ratio was 8.2
(95% CI 3.3–17).
Index cases with aﬀected siblings were distributed
apparently randomly across all grades of socio-econ-
omic status with no obvious bias (grade 1, 22.7%;
grade 2, 9.1%; grade 3, 18.2%; grade 4, 27.3%;
grade 5, 22.7%) and no diﬀerence in social class dis-
tribution was found when MD cases were compared
with the data for England and Wales (P=0.5).
In addition, no diﬀerence in distribution of socio-
economic status was found when the samples were
stratiﬁed according to whether less than, or more than
1 month had elapsed between MD onset in index case
and the aﬀected sibling(s) (P=0.9).
DISCUSSION
This is the ﬁrst study to quantify the increased risk of
MD among siblings of aﬀected cases. Siblings of af-
fected cases are at a 30-fold increased risk of con-
tracting MD. This increased risk of MD is due to both
host (e.g. genetic) and environmental (e.g. exposure to
N. meningitidis) factors. To minimize the risk of over-
estimating the contribution that host genetic factors
make to the total ls value as a result of increased
exposure to N. meningitidis in families with aﬀected
cases, the time elapsing between onset of MD in
aﬀected cases and their sibling(s) was taken into ac-
count. A cut-oﬀ point of 1 month was used as the
eﬀect of N. meningitidis co-exposure on the basis that
acquisition would be minimal after this period given
the practice of prophylactic treatment of all family
members following initial disease, the relatively short
time between acquisition and invasive MD [14–17],
and the cumulative ls data presented in this study.
Subject to this assumption, host genetic factors were
found to contribute approximately one third (ls=11)
of the overall increased risk of MD in siblings of
primary cases (ls=30).
The response rate to the questionnaire was 61%,
but as non-responders are unlikely to diﬀer from re-
sponders in terms of genetic factors, the estimate of
the sibling risk ratio should be unbiased by incom-
plete response. All index cases completing a question-
naire were asked about the number of full siblings,
a variable unlikely to be aﬀected by recall bias.
Another limitation of the study was the validity of
the comparison of expected rates in siblings with
those of the general population. It is possible that the
siblings diﬀered in terms of environmental risk factors
for MD (such as smoking or low socio-economic
status), which might have increased their risk of dis-
ease independently of a genetic eﬀect [20]. This would
tend to inﬂate the estimated sibling risk ratio, although
as mentioned above, we tried to minimize such bias
due to acute environmental exposure by excluding
secondary cases occurring within one month of the
index case. There was also no diﬀerence in the distri-
bution of social classes between cases with MD and
the general population of England and Wales, indi-
cating that the sibling risk ratio was not likely to have
been inﬂated due to an excess of aﬀected sibling pairs
of low socio-economic status.
It is possible that the ls value of 30 calculated in this
study is an underestimation of the sibling risk. As the
number of notiﬁcations recorded by the PHLS in-
cludes possible and probable as well as conﬁrmed
cases of MD, the age-speciﬁc incidence data might
have been overestimated if some of the possible and
probable cases were not in fact MD. If this was the
case, the expected number of aﬀected siblings predicted
by the incidence data would have been lower and the
overall ls value higher. In the calculation of ls, sib-
lings of aﬀected cases whose diagnosis was classiﬁed
as possible or probable MD were excluded, thus
avoiding ls overestimation. Notiﬁcation of MD cases
to the PHLS is known to be incomplete. However,
given the severity of MD, it is more likely that cases
are incorrectly reported as MD, rather than cases of
MD not being reported at all.
Diﬀerences in bacterial virulence are undoubtedly
important in determining the incidence of invasive dis-
ease as speciﬁc subgroups such as the ET-5 and ET-37
complex are implicated in global epidemics [21]. How-
ever, acquisition of a pathogenic strain is not suﬃcient
to determine outcome, since even those colonized with
the same subtype of organism do not develop MD.
As early as 1945 Aycock and Mueller observed that,
although MD incidence varied by season, meningo-
coccal carriage did not, the implication being that
carriage could not be the sole risk factor for MD [22].
Other studies have conﬁrmed this and show no con-
sistent relationship between the number of carriers
in a community and the number of cases of disease
[18, 23]. Episodes of upper respiratory tract infection
may be a predisposing factor for occurrence of
MD [24], however, the incidence of respiratory tract
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infections is much higher than the incidence of MD
and not all studies have found an association between
those suﬀering from upper respiratory tract infections
and invasive MD [25], indicating that other factors
are important.
Given that acquisition and carriage of N. meningi-
tidis are not suﬃcient for disease, the host genetic
contribution to the increased risk of MD in siblings is
probably more than one third of the total risk, as
there is likely to be a genetic component to suscepti-
bility even within siblings who contract MD within
one month of the index case.
Why N. meningitidis shows a dichotomy between a
‘silent’ process (carriage in the upper respiratory
tract) and an overt disease process (invasive disease)
is unknown. This study has highlighted a greatly in-
creased risk of MD amongst siblings of aﬀected cases
and has provided an estimate that host genetics may
contribute approximately one third of this total risk.
In view of the incomplete protection oﬀered to siblings
of cases of MD by administration of prophylactic
antibiotics, the demonstration of a substantial host
genetic component of risk of MD amongst siblings of
cases reinforces the need for very careful counselling
of family members of index cases, and the need to
ensure a high level of familiarity within this group of
the signs and symptoms of MD.
Accurately calculating ls for an infectious disease is
diﬃcult given the increased risk of exposure to infec-
tion in family members compared with the general
population and the variation in disease risk according
to age and calendar year. To our knowledge this is the
ﬁrst time that ls has been calculated for an infectious
disease where both these factors have been taken into
account. The methods used here may give a clearer
indication of the overall role of host genetics in other
infectious diseases.
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